DARDEN REST. INC./ US2371941053 /
2024-05-30 8:08:18 AM | Chg. -2.75 | Volume | Bid8:40:28 AM | Ask8:40:28 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
133.55EUR | -2.02% | 0 Turnover: 0.00 |
133.45Bid Size: 75 | 134.55Ask Size: 75 | 16.13 bill.EUR | - | - |
GlobeNewswire
8:35 AM
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
8:30 AM
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
8:30 AM
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
8:30 AM
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
8:30 AM
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
GlobeNewswire
7:30 AM
Azerion announces expansion of its Executive Committee and new responsibilities